(Q46178938)

20 December 2017

title

Association between C-reactive protein and pre-diabetic status in a Chinese Han clinical population (English)

1 reference

20 December 2017

8

Frank B Hu

1 reference

20 December 2017

Jie Lin

1

1 reference

20 December 2017

Muxun Zhang

2

1 reference

20 December 2017

Fangfang Song

3

1 reference

20 December 2017

Jun Qin

4

1 reference

20 December 2017

Rui Wang

5

1 reference

20 December 2017

Ping Yao

6

1 reference

20 December 2017

Chenjiang Ying

7

1 reference

20 December 2017

Liegang Liu

9

1 reference

20 December 2017

publication date

1 March 2009

1 reference

20 December 2017

Diabetes - Metabolism: Research and Reviews

published in

1 reference

20 December 2017

volume

25

1 reference

20 December 2017

issue

3

1 reference

20 December 2017

page(s)

219-223

1 reference

20 December 2017

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

cites work

1 reference

C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study

21 January 2018

1 reference

The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study

21 January 2018

1 reference

7 January 2021

Genetic variation, C-reactive protein levels, and incidence of diabetes.

1 reference

7 January 2021

Inflammatory markers and risk of developing type 2 diabetes in women

1 reference

7 January 2021

Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study

1 reference

7 January 2021

Elevated C-Reactive Protein Is a Risk Factor for the Development of Type 2 Diabetes in Japanese Americans

1 reference

7 January 2021

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

1 reference

7 January 2021

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

1 reference

7 January 2021

Different contributions of insulin resistance and beta-cell dysfunction in overweight Israeli Arabs with IFG and IGT.

1 reference

7 January 2021

Diagnosis and classification of diabetes mellitus

1 reference

7 January 2021

Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention

1 reference

7 January 2021

Impaired glucose tolerance as a disease

1 reference

7 January 2021

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

1 reference

7 January 2021

Alcohol consumption in relation to metabolic regulation, inflammation, and adiponectin in 64-year-old Caucasian women: a population-based study with a focus on impaired glucose regulation

1 reference

7 January 2021

Oxidative stress, antioxidant status and DNA damage in patients with impaired glucose regulation and newly diagnosed Type 2 diabetes

1 reference

7 January 2021

Leisure time physical activity and the risk of type 2 diabetes in men and women from the general population. The MONICA/KORA Augsburg Cohort Study

1 reference

7 January 2021

Is alcohol use associated with cavitary disease in tuberculosis?

1 reference

7 January 2021

Body mass index, diabetes, and C-reactive protein among U.S. adults

1 reference

7 January 2021

Association between C-reactive protein and insulin resistance in a Japanese population: the Minoh Study

1 reference

7 January 2021

Gender differences in C-reactive protein, interleukin-1 receptor antagonist and adiponectin levels in the metabolic syndrome: a population-based study

1 reference

7 January 2021

Is type II diabetes mellitus a disease of the innate immune system?

1 reference

7 January 2021

Strong decrease of high sensitivity C-reactive protein with high-dose atorvastatin in patients with type 2 diabetes mellitus

1 reference

7 January 2021

Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials

1 reference

7 January 2021

Identifiers

DOI

10.1002/DMRR.923

1 reference

20 December 2017

1 reference

20 December 2017